SCHEMBL25980375

SCHEMBL25980375

c1ccc(-c2ccc(N(c3ccccc3)c3cccc4c3oc3cc(-c5nc(-c6ccccc6)nc(-c6cccc7c6oc6ccccc67)n5)ccc34)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.40
PRKDC P78527 2/20 0.37
ALDH1A1 P00352 3/20 0.36
POLB P06746 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 7/20 0.35
TSHR P16473 3/20 0.35
LMNA P02545 3/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
GGPS1 O95749 1/20 0.33
HSD17B10 Q99714 2/20 0.32
MAPK1 P28482 1/20 0.32
HPGD P15428 1/20 0.32
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CB P42338 1/20 0.32
PTGES2 Q9H7Z7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25980141 0.97 ALOX5 (0.43) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL25980374 0.95 ALOX5 (0.37) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL25980335 0.95 MAPT (0.38) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL25978511 0.94 ALOX5 (0.38) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL25979706 0.94 MAPT (0.38) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL26778873 0.93 ALOX5 (0.37) ALOX5PRKDCALDH1A1POLBKDM4E
SCHEMBL25980061 0.93 MAPT (0.35) ALOX5ALDH1A1POLBKDM4EMAPT
SCHEMBL25980257 0.93 MAPT (0.35) ALOX5ALDH1A1POLBKDM4EMAPT
SCHEMBL25979998 0.93 MAPT (0.35) ALOX5ALDH1A1POLBKDM4EMAPT
SCHEMBL25980276 0.93 MAPT (0.35) ALOX5ALDH1A1POLBKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 ALOX5 660/4885PRKDC 4556/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.